- Home
- SRDX vs HIVE Comparison
SRDX vs HIVE Comparison
Compare SRDX & HIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRDX
- HIVE
- Stock Information
- Founded
- SRDX 1979
- HIVE 1987
- Country
- SRDX United States
- HIVE United States
- Employees
- SRDX N/A
- HIVE N/A
- Industry
- SRDX Medical/Dental Instruments
- HIVE
- Sector
- SRDX Health Care
- HIVE
- Exchange
- SRDX Nasdaq
- HIVE Nasdaq
- Market Cap
- SRDX 457.0M
- HIVE 459.0M
- IPO Year
- SRDX 1998
- HIVE N/A
- Fundamental
- Price
- SRDX $32.03
- HIVE $3.81
- Analyst Decision
- SRDX Buy
- HIVE Strong Buy
- Analyst Count
- SRDX 3
- HIVE 6
- Target Price
- SRDX $43.00
- HIVE $6.83
- AVG Volume (30 Days)
- SRDX 244.1K
- HIVE 27.1M
- Earning Date
- SRDX 11-05-2025
- HIVE 11-12-2025
- Dividend Yield
- SRDX N/A
- HIVE N/A
- EPS Growth
- SRDX N/A
- HIVE 42.43
- EPS
- SRDX N/A
- HIVE 0.34
- Revenue
- SRDX $120,801,000.00
- HIVE $128,649,000.00
- Revenue This Year
- SRDX N/A
- HIVE $170.85
- Revenue Next Year
- SRDX $3.38
- HIVE $52.44
- P/E Ratio
- SRDX N/A
- HIVE $11.30
- Revenue Growth
- SRDX N/A
- HIVE 4.47
- 52 Week Low
- SRDX $26.00
- HIVE $1.26
- 52 Week High
- SRDX $40.39
- HIVE $5.54
- Technical
- Relative Strength Index (RSI)
- SRDX 52.07
- HIVE 58.46
- Support Level
- SRDX $31.34
- HIVE $2.59
- Resistance Level
- SRDX $33.17
- HIVE $3.82
- Average True Range (ATR)
- SRDX 0.70
- HIVE 0.19
- MACD
- SRDX -1.98
- HIVE -0.11
- Stochastic Oscillator
- SRDX 92.20
- HIVE 98.96
About SRDX Surmodics Inc.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
About HIVE HIVE Digital Technologies Ltd.
HIVE Digital Technologies Ltd is in the business of providing infrastructure solutions in the blockchain industry. It focuses on the mining and sale of digital currencies. Its geographical segments include Canada, Sweden, Iceland, Switzerland, and Bermuda, out of which the majority of the revenue comes from Bermuda.